Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2010
06/03/2010US20100137286 Arylcyclohexylethers of dihydrotetraazabenzoazulenes
06/03/2010US20100137282 Tricyclic nitrogen containing compounds as antibacterial agents
06/03/2010US20100137280 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
06/03/2010US20100137276 Compounds which potentiate ampa receptor and uses thereof in medicine
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100133519 Arylamine compounds and electronic devices
06/03/2010CA2743976A1 Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
06/03/2010CA2743241A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/03/2010CA2743097A1 Regioselective reduction of fused pyrrolocarbazoles -5,7-diones
06/03/2010CA2743030A1 3-aminocyclopentanecarboxamides as chemokine receptor modulators
06/03/2010CA2740975A1 Mtor kinase inhibitors for oncology indications and diseases associated with the mtor/p13k/akt pathway
06/02/2010EP2192121A1 Regioselective reduction of fused pyrrolocarbazoles-5,7-diones
06/02/2010EP2190850A1 Small molecule correctors of deltaf508 cftr trafficking
06/02/2010EP2190849A2 Compounds useful as protein kinases inhibitors
06/02/2010EP2190845A2 Hdac inhibitors
06/02/2010EP2190843A1 Benzimidazole nf- kappab inhibitors
06/02/2010EP2190824A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
06/02/2010EP2190815A1 Pyrrolidine aryl-ether as nk3 receptor antagonists
06/02/2010EP2059521B1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
06/02/2010EP2029601B1 Pyridopyrimidinone derivatives
06/02/2010EP1833477B1 Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases
06/02/2010EP1608650B1 Pyrene-linked pyrrolo(2,1-c)(1,4)benzodiazepine derivatives useful as anticancer agents
06/02/2010EP1537116B1 Pyrazolopyrimidines suitable for the treatment of cancer diseases
06/02/2010EP1466914B1 Amorphous substance of tricyclic triazolobenzazepine derivative
06/02/2010CN1840530B Process for preparing pemetrexed
06/02/2010CN1712404B Purification of porphyrin medicine
06/02/2010CN101720328A labelling methods
06/02/2010CN101720327A Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
06/02/2010CN101720325A Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
06/02/2010CN101717403A New green synthesizing process for ketocoumaran compound
06/02/2010CN101717401A Preparing method of phthalocyaninatoaluminium chloride
06/02/2010CN101717400A Synthesis method of 3,7-dinitro-1,3,5,7-4-azabicyclo[3,3,1]nonane
06/02/2010CN101717399A Compound with pyrazine and thiazolone structure and application thereof in preparing medicament for treating diabetes mellitus
06/02/2010CN101265261B Porphyrin-fullerene assembling body and its preparation and use as functional material
06/02/2010CN101260110B Alpha-(8-quinolineoxy)mono-substituted zinc phthalocyanine and preparation method thereof
06/01/2010US7728139 for use as latent pigments; photocopiers
06/01/2010US7728031 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
06/01/2010US7728030 novel indazolyl ester or amide derivatives; N-((1S,2R)-2-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-methyl-2-phenylethyl)cyclopropanecarboxamide; non-steroidal compounds as modulators of the glucocorticoid receptor; acylation
06/01/2010US7728018 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonists
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010CA2457965C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/01/2010CA2438547C Isoxazoline derivative and herbicide containing the same as the active ingredient
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
05/2010
05/27/2010WO2010059836A1 Substituted aza-bridged bicyclics for cardiovascular and cns disease
05/27/2010WO2010059795A1 Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound
05/27/2010WO2010059611A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059610A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058430A1 Process for the preparation of tetrazine derivatives
05/27/2010WO2010058416A1 Quinazolinone linked pyrrolo[2,1 -c][1.4]benzodiazepine hybrids as potential anticancer agents and process forthe preparation thereof
05/27/2010WO2010058414A1 Novel pyrroiol2,l-cu1.41benzodiazepine derivatives with dithiocarbamate side chains and process for the preparation thereof
05/27/2010WO2010057795A1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
05/27/2010WO2010017055A3 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
05/27/2010WO2010013925A3 Pharmacological composition for prevention and treatment of respiratory disease containing pyrazolopyrimidinone compound or pharmaceutically acceptable salts thereof
05/27/2010WO2009153178A3 Aryl ketone as mri
05/27/2010WO2009068955A3 Polymorphs of a c-met/hgfr inhibitor
05/27/2010WO2009051397A9 Novel compounds of reverse turn mimetics and the use thereof (3)
05/27/2010US20100130737 Regulating Agent of GPR34 Receptor Function
05/27/2010US20100130515 Polymorphs and solvates of a pharmaceutical and method of making
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130492 Morpholinopurine derivatives
05/27/2010US20100130490 Csf-1r inhibitors,compositions, and methods of use
05/27/2010US20100130489 Imidazolo-heteroaryl derivatives with antibacterial properties
05/27/2010US20100130488 Pyrazolo-Pyrimidines as Casein Kinase II (CK2) Modulators
05/27/2010US20100130482 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/27/2010US20100130479 Gabaergic Agents to Treat Memory Deficits
05/27/2010US20100130477 Spirocyclobutyl Piperidine Derivatives
05/27/2010US20100130467 Triazolotriazines as kinase inhibitors
05/27/2010US20100129469 Use of dimiracetam in the treatment of chronic pain
05/27/2010US20100127251 Aryl-Aryl Dendrimers
05/27/2010CA2744560A1 Process for the preparation of tetrazine derivatives
05/27/2010CA2744343A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
05/27/2010CA2743497A1 Inhibitors of diacylglycerol acyltransferase
05/27/2010CA2742790A1 Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010CA2739900A1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
05/26/2010EP2188293A1 6-substituted sulfonyl azabicycloý3.2.1¨octanes useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
05/26/2010EP2188292A1 2- [ (2-{phenylamino}-1h-pyrrolo [2, 3-d]pyrimidin-4-yl) amino]benzamide derivatives as igf-1r inhibitors for the treatment of cancer
05/26/2010EP2188291A2 Fused bicyclic pyrimidines
05/26/2010EP2188290A1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents
05/26/2010EP2188289A2 (7h-pyrrolo[2,3-d]pyrimidin-4-yl)-piperazines as kinase inhibitors for the treatment of cancer and inflammation
05/26/2010EP2188288A1 Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
05/26/2010EP2188283A1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
05/26/2010EP2188271A2 Heterocyclic compounds and uses as anticancer agents
05/26/2010EP2187883A2 Nitrogen containing bicyclic chemical entities for treating viral infections
05/26/2010EP2094710B1 3,4 diaminopyridine derivatives
05/26/2010EP2029606B1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
05/26/2010EP1844048B1 Pyrazolopyrimidines as cell cycle kinase inhibitors
05/26/2010EP1603915B1 SUBSTITUTED 8 -PYRIDINYL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE AND 8 -PYRIMIDIN YL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE DERIVATIVES AND THEIR USE AGAINST NEUROGENERATIVE DISEASES
05/26/2010EP1537113B9 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
05/26/2010EP1315709B1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
05/26/2010CN1993361B Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/26/2010CN1953963B Process for producing cyclic N-hydroxyimide compound
05/26/2010CN1922183B Nitrogenous fused heteroaromatic ring derivative
05/26/2010CN1910185B Pyrrolopyrimidine and pyrrolotriazine derivatives as CRF receptor antagon
05/26/2010CN1863804B Certain substituted spirocyclic lactams and use thereof as pharmaceuticals
05/26/2010CN1726217B Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
05/26/2010CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors